ATE185373T1 - Herstellung und anwendung von polypeptiden, die durch bindmolekuele markiert sind - Google Patents

Herstellung und anwendung von polypeptiden, die durch bindmolekuele markiert sind

Info

Publication number: ATE185373T1
Authority: AT; Austria
Prior art keywords: polypeptide; binding; ligand; preparation; calmodulin
Prior art date: 1993-11-04

Application number

AT94931655T

Other languages

English (en)

Inventor

Dario Neri

Gregory Paul Winter

Lalla Claudia Dibit De

Original Assignee

Medical Res Council

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-04

Filing date

1994-11-04

Publication date

1999-10-15

1993-11-04 Priority claimed from GB939322772A external-priority patent/GB9322772D0/en

1994-11-04 Application filed by Medical Res Council filed Critical Medical Res Council

1999-10-15 Application granted granted Critical

1999-10-15 Publication of ATE185373T1 publication Critical patent/ATE185373T1/de

Links

229920001184 polypeptide Polymers 0.000 title abstract 9
108090000765 processed proteins & peptides Proteins 0.000 title abstract 9
102000004196 processed proteins & peptides Human genes 0.000 title abstract 9
230000027455 binding Effects 0.000 title abstract 6
239000003446 ligand Substances 0.000 abstract 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
102000000584 Calmodulin Human genes 0.000 abstract 2
108010041952 Calmodulin Proteins 0.000 abstract 2
238000003556 assay Methods 0.000 abstract 2
229910052791 calcium Inorganic materials 0.000 abstract 2
239000011575 calcium Substances 0.000 abstract 2
230000001419 dependent effect Effects 0.000 abstract 2
230000000295 complement effect Effects 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
238000010494 dissociation reaction Methods 0.000 abstract 1
230000005593 dissociations Effects 0.000 abstract 1
230000004927 fusion Effects 0.000 abstract 1
238000002372 labelling Methods 0.000 abstract 1
MASXKPLGZRMBJF-MVSGICTGSA-N mastoparan Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O MASXKPLGZRMBJF-MVSGICTGSA-N 0.000 abstract 1
108010019084 mastoparan Proteins 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
238000000746 purification Methods 0.000 abstract 1
238000003259 recombinant expression Methods 0.000 abstract 1
230000009870 specific binding Effects 0.000 abstract 1
230000008685 targeting Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4728—Calcium binding proteins, e.g. calmodulin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43568—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from wasps
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Insects & Arthropods (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)

AT94931655T 1993-11-04 1994-11-04 Herstellung und anwendung von polypeptiden, die durch bindmolekuele markiert sind ATE185373T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB939322772A GB9322772D0 (en)	1993-11-04	1993-11-04	Tagging
GB9405927A GB9405927D0 (en)	1993-11-04	1994-03-25	Tagging

Publications (1)

Publication Number	Publication Date
ATE185373T1 true ATE185373T1 (de)	1999-10-15

Family

ID=26303796

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94931655T ATE185373T1 (de)	1993-11-04	1994-11-04	Herstellung und anwendung von polypeptiden, die durch bindmolekuele markiert sind

Country Status (10)

Country	Link
EP (1)	EP0726951B1 (de)
JP (1)	JPH09504694A (de)
AT (1)	ATE185373T1 (de)
AU (1)	AU695107B2 (de)
CA (1)	CA2175209A1 (de)
DE (1)	DE69421086T2 (de)
DK (1)	DK0726951T3 (de)
ES (1)	ES2139761T3 (de)
GR (1)	GR3031943T3 (de)
WO (1)	WO1995012672A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2667197A (en) *	1996-04-16	1997-11-07	University Of Miami	Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
GB9608540D0 (en) *	1996-04-25	1996-07-03	Medical Res Council	Isolation of enzymes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5747334A (en) *	1990-02-15	1998-05-05	The University Of North Carolina At Chapel Hill	Random peptide library

1994
- 1994-11-04 DK DK94931655T patent/DK0726951T3/da active
- 1994-11-04 DE DE69421086T patent/DE69421086T2/de not_active Expired - Fee Related
- 1994-11-04 CA CA002175209A patent/CA2175209A1/en not_active Abandoned
- 1994-11-04 JP JP7513097A patent/JPH09504694A/ja active Pending
- 1994-11-04 WO PCT/GB1994/002420 patent/WO1995012672A1/en not_active Ceased
- 1994-11-04 EP EP94931655A patent/EP0726951B1/de not_active Expired - Lifetime
- 1994-11-04 AU AU80654/94A patent/AU695107B2/en not_active Ceased
- 1994-11-04 AT AT94931655T patent/ATE185373T1/de not_active IP Right Cessation
- 1994-11-04 ES ES94931655T patent/ES2139761T3/es not_active Expired - Lifetime
1999
- 1999-11-25 GR GR990403035T patent/GR3031943T3/el unknown

Also Published As

Publication number	Publication date
EP0726951A1 (de)	1996-08-21
AU695107B2 (en)	1998-08-06
JPH09504694A (ja)	1997-05-13
DK0726951T3 (da)	2000-03-27
CA2175209A1 (en)	1995-05-11
DE69421086T2 (de)	2000-03-02
DE69421086D1 (de)	1999-11-11
EP0726951B1 (de)	1999-10-06
AU8065494A (en)	1995-05-23
GR3031943T3 (en)	2000-03-31
WO1995012672A1 (en)	1995-05-11
ES2139761T3 (es)	2000-02-16

Legal Events

Date	Code	Title	Description
2003-08-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
WO1992010514A3 (en)	1992-08-20	Synthetic antigens for the detection of antibodies to hepatitis c virus
EP1712623A3 (de)	2008-10-15	Selektion von Proteinen unter Verwendung von RNA-protein-fusionen
Hatzfeld et al.	1987	Cytokeratin domains involved in heterotypic complex formation determined by in-vitro binding assays
CA2155185A1 (en)	1994-08-18	Totally synthetic affinity reagents
Kosakowski et al.	1970	The Subunit Structure of Phenylalanyl‐tRNA Synthetase of Escherichia coli
AU1629192A (en)	1993-03-11	Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase
DE69834643D1 (de)	2006-06-29	Adipozyten-spezifische protein homologe
EP0696640A3 (de)	1997-12-29	Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
WO1994026891A3 (en)	1995-01-19	Purified mammalian flt3 ligands and agonists and antagonists thereof
NO180558C (no)	1997-05-07	Ligandholdig medium for kromatografisk adsorpsjon, fremgangsmåte for fremstilling av mediet, samt anvendelse av mediet
Milstein et al.	1971	Disulphide bridges of the heavy chain of human immunoglobulin G2
CA2285571A1 (en)	1998-10-22	Immunomodulatory molecules and process for producing the same
DE69421086D1 (de)	1999-11-11	Herstellung und anwendung von polypeptiden, die durch bindmolekuele markiert sind
WO1999002708A8 (en)	1999-04-01	Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein
Lapko et al.	1998	Surface topography of phytochrome A deduced from specific chemical modification with iodoacetamide
WO1998011130A3 (en)	1998-07-30	Mammalian ependymin-like proteins
EP0806478A3 (de)	1999-06-09	P53as Protein und Antikörper dafür
JPS63145961A (ja)	1988-06-18	固相結合試薬、その製造方法及びそれを含有する検定用キット
WO2001042295A3 (en)	2002-03-21	Clasp-7 transmembrane protein
Sternson et al.	1986	Peptide Analysis: Critical Technology for Evaluating Delivery Approaches
Havran	1966	Chemical Modification of Chymotrypsinogen a With a Bifunctional Reagent
EP1659131A3 (de)	2006-08-23	Polypeptide und dafür kodierende Nukleinsäure
WO2001085908A3 (en)	2009-06-18	Clasp-1 transmembrane protein
WO2001042294A3 (en)	2002-01-03	Clasp-4 transmembrane protein
SG145521A1 (en)	2008-09-29	Synthetic antigens for the detection of antibodies to hepatitis c virus